Barriers to reverse logistics practices in pharmaceutical supply chains: an ISM approach Online publication date: Fri, 31-Aug-2018
by Haidar Abbas
International Journal of Business Excellence (IJBEX), Vol. 16, No. 1, 2018
Abstract: The essence of supply chain management lies in delivering the right product in the right quantity with the right quality to the right customer at the right time, right cost and at the right place. The product may return for customers' dissatisfaction, defect, non-performance, servicing etc. Having attracted the stakeholders' attention long back, practice of reverse logistics still faces issues related with financial resources, technological advancement, commitment of top management, awareness about the legislative measures etc. Identification, classification, and preparation of suitable strategies become the responsibility of the top management. Researchers have tried to establish the impediments of reverse logistics practices in the context of Indian pharmaceutical supply chains. Using the Interpretive Structural Modelling (ISM), researchers tried to establish driving barriers and independent barriers. Based on the degree of driving power and dependency, researchers extracted some crucial barriers that require more attention than others.
Online publication date: Fri, 31-Aug-2018
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Business Excellence (IJBEX):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email email@example.com